PAR 2.50% 19.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2654

  1. 9,938 Posts.
    lightbulb Created with Sketch. 227
    Yes, fair point @hamman, I just cannot understand what that has to do with the delay, there is no change in the number of likely candidates to join, the staff required were all local and in place back in November.

    It just seems like a BS excuse, but you are probably correct - shame the company cannot be forthcoming to explain!

    Cheers and GLTA

    Cabe
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.